{
    "Trade/Device Name(s)": [
        "Precision\u00ae Point of Care Blood Glucose Test Strip",
        "Optium\u00ae Point of Care Blood Glucose Test Strip"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K070984",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021960"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFR",
        "NBW"
    ],
    "Summary Letter Date": "October 10, 2007",
    "Summary Letter Received Date": "October 15, 2007",
    "Submission Date": "October 09, 2007",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose (D-glucose)"
    ],
    "Specimen Type(s)": [
        "Fresh neonatal whole blood",
        "Venous whole blood",
        "Arterial whole blood",
        "Fingertip capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Precision Xtra\u00ae Blood Glucose Monitoring System",
        "Optium\u00ae Blood Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric biosensor technology",
        "Enzyme (Glucose Dehydrogenase, GDH) catalyzed reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Precision and Optium Point of Care Blood Glucose Test Strips for quantitative measurement of glucose using amperometric biosensor technology",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh neonatal, venous, arterial and fingertip capillary whole blood; for in vitro diagnostic use by healthcare professionals in facilities, or by home users for capillary samples only, as an aid in monitoring effectiveness of diabetes control programs, not for diagnosis or screening of diabetes mellitus",
    "fda_folder": "Clinical Chemistry"
}